21 /100
LOW RISK
Score updated Apr 28, 2026

SPRY

ARS Pharmaceuticals, Inc. — Stock Dilution Tracker

Track SPRY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track SPRY — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
55
⚠️ Warrant Exposure
15
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for SPRY.
🔔 Track SPRY — Get forecast alerts →
💹 Market Data
Market Cap$785.87M
Shares Outstanding99.30M
Float41.04M
Cash$244.99M
Debt$168.51M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 7.5% shares (2025Q4 vs prior)
192 institutional holders · 92.91M shares
#1 RA CAPITAL MANAGEMENT, L.P. 10.86M shares
#2 ORBIMED ADVISORS LLC 8.29M shares
#3 DEERFIELD MANAGEMENT COMPANY, L.P. 7.50M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest26.76M
Days to Cover21.2
% of Float65.2%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2022
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
Track SPRY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SPRY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAPL AAUAF ABLZF ACIW
🔬 More Research for SPRY
📊 SPRY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SPRY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.